🔍 RecallPedia

Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06

Class I - Dangerous
💊 Drugs Recalled: August 23, 2016 Stason Pharmaceuticals Prescription Drugs

What Should You Do?

  1. Check if you have this product:
    Lot #: 14F030, 14F031, 14F032, Exp. June 2017; 15G022, Exp. July 2018
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Stason Pharmaceuticals, Inc.
Reason for Recall:
Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06

Product Codes/Lot Numbers:

Lot #: 14F030, 14F031, 14F032, Exp. June 2017; 15G022, Exp. July 2018

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1479-2016

Related Recalls